An endogenous dopaminergic neurotoxin: Implication for Parkinson's disease

https://doi.org/10.1016/1055-8330(95)90016-0Get rights and content

Abstract

Oxidation of dopamine by monoamine oxidase results in the endogenous metabolite 3,4-dihydroxyphenylacetaldehyde (DOPAL). The toxicity of DOPAL for dopaminergic neurons was investigated using rat neostriatal synaptosomes, PC-12 cells and cultures of fetal rat dissociated mesencephalon. The Na+-dependent uptake of [3H]DOPAL in synaptosomes was inhibited by mazindol. DOPAL selectively inhibited dopamine uptake but not [14C]GABA uptake, induced membrane damage and liberation of dopamine into the medium. Incubation of PC-12 cells with 6.5 μM of DOPAL for 24 h caused degeneration of the neuritic process, and the number of viable cells were reduced by 25% of control. There were practically no surviving cells after 24 h of incubation with 33 μM of DOPAL. After 8 h of treatment with 33 μM of DOPAL, dopamine and 3,4-dihydroxyphenylacetic acid content in the cells were reduced by 38% and 53% of control. DOPAL-induced cell damage released lactic acid dehydrogenase into the incubation media. This toxic effect of DOPAL was time- and concentration-dependent. In mesencephalic cultures, after exposure to 33 μM of DOPAL, the surviving TH+ cells showed rounded cell body, and fibre network was highly reduced. These results indicate DOPAL is a neurotoxin and may be involved in the degeneration of dopaminergic neurons.

References (37)

  • CM Tanner

    The role of environmental toxins in the etiology of Parkinson's disease

    Trends Neurosci

    (1989)
  • WG Tatton et al.

    Transmitter synthesis increase in substantia nigra neurons of the aged mouse

    Neurosci Lett

    (1991)
  • DB Calne et al.

    Compensatory mechanism in degenerative neurological diseases

    Insight from parkinsonism

    Arch Neurol

    (1991)
  • S Fahn

    The endogenous toxin hypothesis of the etiology of Parkinson's disease and a pilot trial of high-dosage antioxidant in an attempt to slow the progression of the illness

    Ann NY Acad Sci

    (1989)
  • S Fahn et al.

    The oxidant stress hypothesis in Parkinson's disease: evidence supporting it

    Ann Neurol

    (1992)
  • JM Fearnley et al.

    Ageing and Parkinson's disease: substantia nigra regional selectivity

    Brain

    (1991)
  • RJ Gay et al.

    Optimum reaction conditions for human lactate dehydrogenase isoenzymes as they affect total lactate dehydrogenase activity

    Clin Chem

    (1968)
  • LA Greene et al.

    Establishment of a nonadrenergic clonal line of rat adrenal pheochromocytoma cells which respond to nerve growth factor

  • Cited by (0)

    View full text